Merit Medical Systems Shares Outstanding 2010-2024 | MMSI

Merit Medical Systems shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Merit Medical Systems shares outstanding for the quarter ending December 31, 2024 were 0.059B, a 1.73% increase year-over-year.
  • Merit Medical Systems 2024 shares outstanding were 0.059B, a 1.73% increase from 2023.
  • Merit Medical Systems 2023 shares outstanding were 0.058B, a 1.19% increase from 2022.
  • Merit Medical Systems 2022 shares outstanding were 0.058B, a 0.54% increase from 2021.
Merit Medical Systems Annual Shares Outstanding
(Millions of Shares)
2024 59
2023 58
2022 58
2021 57
2020 55
2019 56
2018 54
2017 50
2016 45
2015 45
2014 43
2013 43
2012 43
2011 40
2010 36
2009 36
Merit Medical Systems Quarterly Shares Outstanding
(Millions of Shares)
2024-12-31 59
2024-09-30 60
2024-06-30 59
2024-03-31 59
2023-12-31 58
2023-09-30 58
2023-06-30 58
2023-03-31 58
2022-12-31 58
2022-09-30 58
2022-06-30 58
2022-03-31 58
2021-12-31 57
2021-09-30 58
2021-06-30 57
2021-03-31 57
2020-12-31 55
2020-09-30 56
2020-06-30 55
2020-03-31 55
2019-12-31 56
2019-09-30 55
2019-06-30 57
2019-03-31 56
2018-12-31 54
2018-09-30 55
2018-06-30 52
2018-03-31 52
2017-12-31 50
2017-09-30 52
2017-06-30 51
2017-03-31 46
2016-12-31 45
2016-09-30 45
2016-06-30 45
2016-03-31 45
2015-12-31 45
2015-09-30 45
2015-06-30 45
2015-03-31 44
2014-12-31 43
2014-09-30 43
2014-06-30 43
2014-03-31 43
2013-12-31 43
2013-09-30 43
2013-06-30 43
2013-03-31 43
2012-12-31 43
2012-09-30 43
2012-06-30 42
2012-03-31 42
2011-12-31 40
2011-09-30 43
2011-06-30 38
2011-03-31 36
2010-12-31 36
2010-09-30 35
2010-06-30 36
2010-03-31 36
2009-12-31 36
2009-09-30 36
2009-06-30 36
2009-03-31 36
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $6.033B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47